Author:
Buranaphatthana Worakanya,Yavirach Apichai,Leaf Elizabeth M.,Scatena Marta,Zhang Hai,An Jonathan Y.,Giachelli Cecilia M.
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference44 articles.
1. American Association of Oral and Maxillofacial Surgeons, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update;Ruggiero;J. Oral Maxillofac. Surg.,2014
2. Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015;Khan;Osteoporos. Int.,2015
3. M. R. Allen, S. L. Ruggiero, A review of pharmaceutical agents and oral bone health: how osteonecrosis of the jaw has affected the field., Int. J. Oral Maxillofac. Implants 29, e45–57.
4. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice;Williams;Am. J. Pathol.,2014
5. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases;Saad;Ann. Oncol.,2012
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献